Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
Accelerated trajectory of CV risk predicts dementia risk
Apr 21, 2022
Those with an accelerated versus stable cardiovascular risk trajectory have an increased risk for memory decline.
Hypertension linked to increased risk for severe COVID-19
Nov 10, 2022
Elevated systolic blood pressure showed a dose-response relationship with severe COVID-19 for those taking antihypertensive meds.
Early-onset HTN, type 2 diabetes linked to early-onset glaucoma
Sep 09, 2022
Age at hypertension and type 2 diabetes diagnoses were linked to age at the onset of primary open-angle glaucoma. No link was found for obstructive sleep apnea or migraine.
Hypertension linked to hospitalization for omicron in vaccinated persons
Aug 09, 2022
The findings were seen among individuals who received at least three mRNA vaccine doses and in whom COVID-19 subsequently was diagnosed during omicron surge.
Worsening BP outcomes seen in HTN patients during pandemic
Nov 03, 2022
Systolic and diastolic blood pressure increased by 1.79 and 1.30 mm Hg, respectively, during the pandemic versus the prepandemic period.
Blood pressure down with self-monitoring of BP, self-titration of medications
May 10, 2024
A reduction was seen in systolic and diastolic blood pressure with self-monitoring plus self-titration of antihypertensive medications.
Prior statin use linked to reduced risk for death in COVID-19
Jul 21, 2021
The risk for death was significantly reduced with prior statin and/or antihypertensive use among those with a history of cardiovascular and/or hypertension.
Tirzepatide improves 24-hour BP in obesity-related hypertension
Feb 07, 2024
A reduction was noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10 15 mg tirzepatide versus placebo.
Polypill not linked to reduced cognitive decline in seniors
Jan 30, 2023
But a polypill with or without aspirin is associated with reduced functional decline for those aged 65 years or older with cardiovascular risk factors.